ARS Pharmaceuticals Inc (NASDAQ:SPRY) currently has a daily average trading volume of 1.11M but it saw 963477 shares traded in last market. With a market cap of 1.56B USD, the company’s current market price of $16.13 came falling about -2.36 while comparing to the previous closing price of $16.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.66 and as low as $3.35. In the recent trading on the day, stock has struck highest price mark of $15.9602 while lowest mark touched by it was $16.89.
Taking a look at 20-day trading activity of ARS Pharmaceuticals Inc (SPRY) gives us an average price of $14.48, while its current price level is -3.18% below from 52-week high level whereas it is 381.49% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $13.45 while that of 200 days or SMA-200 reads an average of $9.80. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.14% during that period while stretching the period over a month that decreases to 6.04%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 67.52 which implies that the stock is in neutral territory.
Raymond James upgraded its recommendation for the stock as a “Strong Buy” from “Outperform” on August 13, 2024 while assigning a price target range of $18-$22. Leerink Partners issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $19 and $20.
Over the week, SPRY’s stock price is moving 15.96% up while it is 14.80% when we observe its performance for the past one month. Year-to-date it is 194.34% up and over the past year, the stock is showing an upside performance of 339.51%.
Currently, ARS Pharmaceuticals Inc’s total number of outstanding shares is 96.41M. Company’s return on investment (ROI) stands at -20.83% and return on equity (ROE) at -19.34%. Stock’s beta reads 0.91. Stock has a price to book (P/B) ratio of 7.26 while price to sale or P/S ratio amounts to 3127.28. Its return on asset (ROA) is -18.66% on average.
